Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 8 results for "bristol myers squibb"

Personalised vaccines hold cancer at bay in two early trials

Although so-called immunotherapy drugs from the likes of Merck & Co, Bristol-Myers Squibb and Roche are starting to revolutionise cancer care, they still only work for a limited number of patients. DNA, 2 weeks ago

111 images for bristol myers squibb

WKRB News, 5 months ago
WKRB News, 5 months ago
WKRB News, 5 months ago
Live Trading News, 5 months ago
World Pharma News, 5 months ago
Live Trading News, 6 months ago
American Banking News, 5 months ago
Cancer Therapy Advisor, 6 months ago
PharmaVOICE, 6 months ago, 6 months ago

U.S. Supreme Court ruling threatens massive talc litigation against J&J

Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer. New Jersey-based J&J has been battling a series of ...
 Sify1 month ago U.S. Supreme Court limits where companies can be sued  DNA1 month ago

US STOCKS-Wall St dips; 2017's laggards tick up, Apple slips

* Herbalife falls after cutting quarterly forecast * Apple slips as new services, hardware introduced * Energy sector up despite crude fall * Dow down 0.1 pct, S&P 500 down 0.12 pct, Nasdaq down 0.16pct(Updates to market close, changes comment, byline) By ...
 Sify1 month ago

PREVIEW-Cancer meeting to provide clues on future immunotherapy combos

This year it will feature more than 250 presentations involving immune-system-boosting drugs known as checkpoint inhibitors, with the lion's share of research focused on drugs that target a protein called PD-1, including Merck & Co Inc's Keytruda, ...
 DNA1 month ago PREVIEW: Cancer meeting to provide clues on future immunotherapy combos  DNA1 month ago

AstraZeneca immunotherapy wins first approval in bladder cancer

⇒ Bladder cancer marks first approval for AZ's durvalumab ⇒ Big market is in lung cancer, where data due mid-year ⇒‚Äč AstraZeneca sets durvalumab price at $15,000/month US regulators have approved AstraZeneca's key immunotherapy drug ...
 DNA2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less